-
1
-
-
3543140687
-
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
-
Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004; 200: 277-85.
-
(2004)
J Exp Med
, vol.200
, pp. 277-285
-
-
Ehrenstein, M.R.1
Evans, J.G.2
Singh, A.3
Moore, S.4
Warnes, G.5
Isenberg, D.A.6
-
2
-
-
0141796312
-
TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
-
Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L,. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9: 1202-8.
-
(2003)
Nat Med
, vol.9
, pp. 1202-1208
-
-
Belghith, M.1
Bluestone, J.A.2
Barriot, S.3
Megret, J.4
Bach, J.F.5
Chatenoud, L.6
-
3
-
-
26444515022
-
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
-
Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC,. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115: 2904-13.
-
(2005)
J Clin Invest
, vol.115
, pp. 2904-2913
-
-
Bisikirska, B.1
Colgan, J.2
Luban, J.3
Bluestone, J.A.4
Herold, K.C.5
-
4
-
-
0037198420
-
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
-
Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346: 1692-8.
-
(2002)
N Engl J Med
, vol.346
, pp. 1692-1698
-
-
Herold, K.C.1
Hagopian, W.2
Auger, J.A.3
Poumian-Ruiz, E.4
Taylor, L.5
Donaldson, D.6
-
6
-
-
79551715405
-
Human CD3 transgenic mice: Preclinical testing of antibodies promoting immune tolerance
-
Kuhn C, You S, Valette F, Hale G, van Endert P, Bach JF, et al. Human CD3 transgenic mice: preclinical testing of antibodies promoting immune tolerance. Sci Transl Med 2011; 3: 68ra10.
-
(2011)
Sci Transl Med
, vol.3
, pp. 68ra10
-
-
Kuhn, C.1
You, S.2
Valette, F.3
Hale, G.4
Van Endert, P.5
Bach, J.F.6
-
7
-
-
20044375937
-
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
-
Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, et al. A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005; 54: 1763-9.
-
(2005)
Diabetes
, vol.54
, pp. 1763-1769
-
-
Herold, K.C.1
Gitelman, S.E.2
Masharani, U.3
Hagopian, W.4
Bisikirska, B.5
Donaldson, D.6
-
8
-
-
20544443927
-
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
-
Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352: 2598-608.
-
(2005)
N Engl J Med
, vol.352
, pp. 2598-2608
-
-
Keymeulen, B.1
Vandemeulebroucke, E.2
Ziegler, A.G.3
Mathieu, C.4
Kaufman, L.5
Hale, G.6
-
9
-
-
80051471700
-
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
-
for the Protégé Trial Investigators
-
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, et al, for the Protégé Trial Investigators. Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial. Lancet 2011; 378: 487-97.
-
(2011)
Lancet
, vol.378
, pp. 487-497
-
-
Sherry, N.1
Hagopian, W.2
Ludvigsson, J.3
Jain, S.M.4
Wahlen, J.5
Ferry, R.J.6
-
10
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
-
11
-
-
74849107553
-
Anti-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis
-
Notley CA, McCann FE, Inglis JJ, Williams RO,. Anti-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis. Arthritis Rheum 2010; 62: 171-8.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 171-178
-
-
Notley, C.A.1
McCann, F.E.2
Inglis, J.J.3
Williams, R.O.4
-
12
-
-
84869020571
-
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
-
McGovern JL, Nguyen DX, Notley CA, Mauri C, Isenberg DA, Ehrenstein MR,. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum 2012; 64: 3129-38.
-
(2012)
Arthritis Rheum
, vol.64
, pp. 3129-3138
-
-
McGovern, J.L.1
Nguyen, D.X.2
Notley, C.A.3
Mauri, C.4
Isenberg, D.A.5
Ehrenstein, M.R.6
-
13
-
-
84860228482
-
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice
-
Takiishi T, Korf H, Van Belle TL, Robert S, Grieco FA, Caluwaerts S, et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 2012; 122: 1717-25.
-
(2012)
J Clin Invest
, vol.122
, pp. 1717-1725
-
-
Takiishi, T.1
Korf, H.2
Van Belle, T.L.3
Robert, S.4
Grieco, F.A.5
Caluwaerts, S.6
-
15
-
-
33846446041
-
Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β
-
Nadkarni S, Mauri C, Ehrenstein MR,. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J Exp Med 2007; 204: 33-9.
-
(2007)
J Exp Med
, vol.204
, pp. 33-39
-
-
Nadkarni, S.1
Mauri, C.2
Ehrenstein, M.R.3
-
16
-
-
0037963473
-
Blood monocytes consist of two principal subsets with distinct migratory properties
-
Geissmann F, Jung S, Littman DR,. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
-
(2003)
Immunity
, vol.19
, pp. 71-82
-
-
Geissmann, F.1
Jung, S.2
Littman, D.R.3
-
19
-
-
0028866022
-
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
-
Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
-
(1995)
Cell
, vol.83
, pp. 793-802
-
-
Grell, M.1
Douni, E.2
Wajant, H.3
Lohden, M.4
Clauss, M.5
Maxeiner, B.6
-
21
-
-
36749081557
-
Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes
-
Evans HG, Suddason T, Jackson I, Taams LS, Lord GM,. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A 2007; 104: 17034-9.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 17034-17039
-
-
Evans, H.G.1
Suddason, T.2
Jackson, I.3
Taams, L.S.4
Lord, G.M.5
-
22
-
-
58049196774
-
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
-
Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR,. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 2008; 105: 19396-401.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 19396-19401
-
-
Flores-Borja, F.1
Jury, E.C.2
Mauri, C.3
Ehrenstein, M.R.4
-
24
-
-
77949908711
-
+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control
-
+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 2010; 184: 1690-701.
-
(2010)
J Immunol
, vol.184
, pp. 1690-1701
-
-
Nigam, P.1
Velu, V.2
Kannanganat, S.3
Chennareddi, L.4
Kwa, S.5
Siddiqui, M.6
-
27
-
-
78649900433
-
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
-
Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Gregoire S, et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010; 120: 4558-68.
-
(2010)
J Clin Invest
, vol.120
, pp. 4558-4568
-
-
Grinberg-Bleyer, Y.1
Saadoun, D.2
Baeyens, A.3
Billiard, F.4
Goldstein, J.D.5
Gregoire, S.6
-
29
-
-
84868629269
-
TNF signaling drives myeloid-derived suppressor cell accumulation
-
Zhao X, Rong L, Zhao X, Li X, Liu X, Deng J, et al. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012; 122: 4094-104.
-
(2012)
J Clin Invest
, vol.122
, pp. 4094-4104
-
-
Zhao, X.1
Rong, L.2
Zhao, X.3
Li, X.4
Liu, X.5
Deng, J.6
-
30
-
-
0346100668
-
Regulation of TCR-mediated T cell activation by TNF-RII
-
Aspalter RM, Eibl MM, Wolf HM,. Regulation of TCR-mediated T cell activation by TNF-RII. J Leukoc Biol 2003; 74: 572-82.
-
(2003)
J Leukoc Biol
, vol.74
, pp. 572-582
-
-
Aspalter, R.M.1
Eibl, M.M.2
Wolf, H.M.3
-
31
-
-
21544434331
-
P38 MAP kinase inhibitors: Many are made, but few are chosen
-
Dominguez C, Powers DA, Tamayo N,. p38 MAP kinase inhibitors: many are made, but few are chosen. Curr Opin Drug Discov Devel 2005; 8: 421-30.
-
(2005)
Curr Opin Drug Discov Devel
, vol.8
, pp. 421-430
-
-
Dominguez, C.1
Powers, D.A.2
Tamayo, N.3
|